Home » Topics » BioWorld Science

BioWorld Science
RSS

Nimbus Therapeutics announces new financing

June 6, 2018

Axovant licenses gene therapy for Parkinson's disease from Oxford BioMedica

June 6, 2018

Independent DMC completes last intermediate review of SCiStar study of AST-OPC1

June 6, 2018

Kyowa Hakko Kirin, Leo Pharma launch Dovobet gel new formulation for psoriasis vulgaris in Japan

June 6, 2018

FDA provides feedback for phase III program of efgartigimod in myasthenia gravis

June 6, 2018

AbbVie seeks Japanese approval for Humira in hidradenitis suppurativa

June 6, 2018

Navitor Pharmaceuticals divulges mTOR complex 1 and glucose transport inhibitors

June 6, 2018

Spyryx presents positive data for first cohort of HOPE-1 phase II trial of SPX-101

June 6, 2018

Ionis and Biogen close strategic collaboration to develop antisense drugs for neurological diseases

June 6, 2018

MONALEESA-3, CDK4/6 inhibition with ribociclib in the de novo metastatic breast cancer setting

June 6, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...